INN offers investors a growing list of all cannabis-related companies listed on the TSX.
The business of cannabis has risen in the past few years, and with the potential of recreational use legalization in the horizon for Canada, companies have been able to enter the big leagues of stock trading by breaking into the Toronto Stock Exchange (TSX).
The TSX has seen leaders of the cannabis industry join its listing and offer investors a new venue for cannabis ventures. These include massive license producers (LPs) expanding their product and brands overseas.
These companies are leaders in the industry thanks to their rapid growth and capability to upgrade into the TSX. They lead in terms of large-scale developments and the means of their cannabis production.
Here the Investing News Network (INN) offers investors a growing list of all cannabis-related companies listed on the TSX.
Also licensed under the ACMPR, much like other companies on the Canadian marijuana stocks, Aphria is located in Leamington, Ontario. The company self-describes itself as “truly powered by sunlight”, which they state allows for natural growing conditions to produce safe medical cannabis products.
Aphria made its strategic entrance to the US cannabis market through Liberty Health Sciences (CSE:LHS; OTCBB:LHSIF), which seeks and partners with cannabis companies in the US. Their first market is in Florida. Despite its interest in the American market, the company was forced to dump its assets south of the border due to regulations issues with the TMX Group. Aphria sold its stake in an Arizona producer to Liberty Health and plans to let go of its own stake in Liberty Health.
Aurora Cannabis (TSX:ACB)
Next on our Canadian cannabis stocks is Aurora Cannabis. This company is currently fast at work on the development of their Aurora Sky facility, an 800,000 square foot hybrid greenhouse, which obtained its cultivation license from Health Canada, the country’s regulator.
As part of their most recent quarterly update to shareholders the company revealed it had reached $11.7 million in revenue for the second quarter of their fiscal 2018 year. The company also shared some details on one of their most recent partnerships, an investment deal with Liquor Stores N.A. meant to plan for the creation of cannabis retail outlets.
The company explained its new investee will convert existing retail locations into specific cannabis outlets while also looking for new spaces to develop.
Now the company continues its path of acquisitions by announcing a deal to purchase MedReleaf (TSX:LEAF). The deal is worth over C$3 billion to buy all the issued and outstanding common shares of MedReleaf.
CannTrust Holdings (TSX:TRST)
CannTrust became the sixth LP to join the TSX when its shares officially launched in the premier Canadian exchange on March 5. The company skipped the TSX Venture exchange entirely and upgraded from the Canadian Securities Exchange (CSE).
“Graduating to the TSX reflects the amazing progress we have made since listing on the CSE in August last year and represents yet another important milestone for CannTrust as we continue our successful journey as one of Canada’s leading cannabis companies” Eric Paul, CEO of CannTrust said.
This year CannTrust managed to complete a $15,000,000 mortgage financing deal for its greenhouse facility in Niagara.
Canopy Growth (TSX:WEED)
Canopy Growth is the largest Canadian cannabis stock, having been the first cannabis organization to surpass the $1 billion market cap.
Canopy holds producers Tweed and Bedrocan under its umbrella. Tweed’s production facility is located in the old Hershey factory in Smith Falls, Ontario, while its breeding facility was completed in September 2016. The company believes the state-of-the-art facility is the first of its kind and will form the foundation of new Canadian-bred genetics.
Canopy regularly announces new deals and partnerships with international emerging markets. Late in 2017, the company announced a deal that sent a signal to the entire industry. Constellation Brands (NYSE:STZ), a massive alcohol producer in the US, invested in 9.9 percent equity of Canopy, which signaled the increased credibility of the cannabis business to the overall market.
MedReleaf is one of the Canadian cannabis stocks whose company is working to advance the knowledge available on the therapeutic benefits of cannabis for patient care. At the Canaccord cannabis investor day conference, they revealed throughout 2018 their four primary areas of focus included the Canadian medical cannabis market and opportunities over in the international market.
The company was rumored to begin a process of making players know the company was available for the taking. The rumors were then confirmed once an acquisition deal with Aurora Cannabis was announced.
Publicly launched this year, this company counts with the backing from major Canadian LP Aurora Cannabis, even appointing Cam Battley, chief corporate officer with Aurora, into TGOD’s board of directors.
The company was able to close its initial public offering with gross proceeds worth $132,263,225 under the IPO thanks in part to issue an additional 36,236,500 units of the company, and including the over-allotment units to financial institutions.
“The further investments by Aurora Cannabis… in both the IPO and the Over-Allotment Option bring Aurora’s total investment in the Company to $78,145,562 and further validate TGOD’s business plan and value,” Robert Anderson, TGOD’s Co-Chairman and CEO said in a statement.
Did we miss a company that you think should be included on the Canadian marijuana stocks list? Let us know in the comments!
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
Editorial Disclosure: The Green Organic Dutchman is a client of the Investing News Network. This article is not paid-for content.